The Combined use of Calcitonin Doubling time and 18F-FDG PET/CT Improves Prognostic Values in Medullary Thyroid Carcinoma: the Clinical Utility of 18F-FDG PET/CT
Authors:
- Ji H. YangJYJi H. Yang
- ClÉBer P. CamachoCCClÉBer P. Camacho
- Susan C. LindseySLSusan C. Lindsey
- Flavia O.F. ValenteFVFlavia O.F. Valente
- Danielle M. AndreoniDADanielle M. Andreoni
- Lilian Y. YamagaLYLilian Y. Yamaga
- Jairo WagnerJWJairo Wagner
- Rosa Paula M. BiscollaRBRosa Paula M. Biscolla
- Rui M.B. MacielRui M.B. Maciel
- 1 August 2017
- journal article
- research article
- Published by Elsevier in Endocrine Practice
- Vol. 23 (8) , 942-948
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- THERAPY OF ENDOCRINE DISEASE: Response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysisEuropean Journal of Endocrinology, 2015
- Advances in thyroid cancer treatment: latest evidence and clinical potentialTherapeutic Advances in Medical Oncology, 2014
- Need for a Revised Staging Consensus in Medullary Thyroid Carcinoma2009
- The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective studyEuropean Journal of Surgical Oncology, 2008
- Biochemical Markers in the Follow-up of Medullary Thyroid CancerThyroid®, 2006
- Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid DisordersThe Journal of Clinical Endocrinology & Metabolism, 2004
- Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imagingBritish Journal of Cancer, 2003
- Medullary thyroid carcinomaCancer, 2000
- Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patientsClinical Endocrinology, 1998
- Medullary thyroid carcinoma.Importance of serial serum calcitonin measurementCancer, 1979